Iqvia inks genomics deal to advance discovery of precision meds

By Flora Southey contact

- Last updated on GMT

(Image: Getty/alexeynovikov)
(Image: Getty/alexeynovikov)

Related tags: Genomics, IQVIA

Iqvia says its collaboration with Genomics England will help drugmakers and academics draw insights from clinical-genomic datasets – the ‘future of real-world research.’

As per the agreement, Genomics England’s patient-consented, de-identified datasets will be incorporated into Iqvia’s E360 analytics platform for use by authorised researchers.

Genomics England was set up by the Department of Health and Social Care to deliver the 100,000 Genomes Project​ – a project designed to sequence whole genomes from national health system (NHS) patients and their families.

According to Iqvia, connecting clinical-genomic datasets will enable drugmakers and researchers to run association studies of genomics and observable traits, safety trials, and burden-of-illness, as well as discovery analytics.

“Our collaboration advances the analysis of these complex datasets, which could accelerate the discovery of precision therapies, [and] improve access and health outcomes,”​ said Iqvia’s president of real-world and analytics solutions, Jon Resnick.

“Drawing insights from clinical-genomics datasets is the future of real-world research,”​ he added.

The alliance marks Iqvia’s latest investment in the clinical research space, following the firm’s launch of a virtual, patient-centric Study Hub in June this year​, and plans to expand​ an alliance with Salesforce to release automated clinical trial processes.

Related news

Show more

Related products

show more

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 15-Aug-2022 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

Standardizing data with NCI controlled terminology

Standardizing data with NCI controlled terminology

Formedix | 18-Jul-2022 | Technical / White Paper

The use of consistent terminology within and between studies is critical to enabling an efficient trial process. CDISC standards such as CDASH, SDTM, SEND...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Related suppliers

Follow us

Products

View more

Webinars